Search Results - "S L Gutorov"

Erlotinib: How to increase the duration of effective use of tyrosine kinase inhibitors in non-small cell lung cancer with EGFR mutation by Borisova, E. I., Gutorov, S. L.

“…Tyrosine kinase inhibitors of the first, second and third generations are the main treatment method for non-small cell lung cancer with EGFR mutation. About…”
Get full text

The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary by Kononenko, I. B., Filippova, M. G., Snegovoy, A. V., Gutorov, S. L.

“…Background. The search and use of new molecular prognostic and predictive markers of efficacy detected by liquid biopsy are aimed at understanding the biology…”
Get full text

Treatment tactics of non-small-cell lung cancer with erlotinib: literature review and description of a clinical case by Borisova, E. I., Gutorov, S. L., Abramov, M. E.

“…Erlotinib is a small-molecule inhibitor of EGFR tyrosine kinase domain, which has shown effectiveness in the treatment of non-small cell lung cancer with…”
Get full text

The role of erythropoietins in cancer therapy by O. E. Kondratieva, M. E. Abramov, G. V. Vyshinskaya, S. L. Gutorov, E. I. Borisova, E. V. Cherniglazova

“…Anemia is a common hematological complication in cancer patients receiving chemotherapy. Reduction of hemoglobin level is accompanied by a significant…”
Get full text

Three benefits of toremifene, or a trend in the current hormone therapy by E. I. Borisova, S. L. Gutorov

“…Introduction of toremifene into clinical practice significantly enhances the potential of current endocrine therapy for luminal subtypes of breast cancer…”
Get full text

Afatinib: new treatment options for lung cancer with activating EGFR mutations by M. V. Stepanchenko, V. G. Zaitsev, S. L. Gutorov

“…First generation EGFR inhibitors have significantly improved the outcomes of drug treatment of patients with metastatic NSCLC, as well as notably increased the…”
Get full text

SPINAL METASTASES IN BREAST CANCER PATIENTS. PROGNOSTIC FACTORS by М. D. Aliev, A. M. Stepanova, E. R. Musaev, A. К. Valiev, S. L. Gutorov

“…The review presents the recent data on factors affecting life expectancy and cancer prognosis in patients with disseminated breast cancer with spinal metastases…”
Get full text

Podderzhivayushchaya terapiya nemelkokletochnogo raka legkogo by S L Gutorov, E I Borisova

Get full text

Ratsional'noe lekarstvennoe lechenienemelkokletochnogo raka legkogo by E I Borisova, S L Gutorov

Get full text

Tselesoobraznost' prodolzheniya terapii bevatsizumabom posle progressirovaniya u bol'nykh metastaticheskim kolorektal'nym rakom by N V Dobrova, S L Gutorov, E V Chernoglazova

Get full text

Ftorafur®. Perspektivy primeneniya v sovremennoy klinicheskoy onkologii by S L Gutorov

“…Идея создания или достижения постоянной максимально высокой концентрации 5-фторурацила (5-ФУ) в клетках опухоли привела к клинической разработке метода его…”
Get full text

Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin by E I Borisova, I Yu Voronina, S L Gutorov

“…Рак молочной железы (РМЖ) у мужчин встречается редко и составляет примерно 1% всех случаев РМЖ. Количество наблюдений как у отдельных исследователей, так и в…”
Get full text

Rezul'taty rossiyskogo mnogotsentrovogoissledovaniya po izucheniyu vozmozhnostiispol'zovaniya klinicheskikh prediktorov dlyaotbora bol'nykh nemelkokletochnym rakomlegkogo na terapiyu erlotinibom by A V Smolin, V I Borisov, S V Orlov, S L Gutorov, A A Fedenko, N A Karaseva, D D Khaliyarova

Get full text

INTEGRATION OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER CHEMOTHERAPY REGIMENS IN 2 CLINICAL CENTERS IN MOSCOW AND SAINT PETERSBURG by N. V. Dobrova, N. N. Semenov, G. M. Manikhas, N. Yu. Antimonik, Yu. V. Vakhabova, S. L. Gutorov

“…The aim of this study was to estimate efficacy of first line chemotherapy with bevacizumab in metastatic colorectal cancer patients and investigate the impact…”
Get full text

PREOPERATIVE CHEMOTHERAPY FOR COLORECTAL CANCER LIVER METASTASES: SHORT-TERM RESULTS by E. V. Chernoglazova, G. V. Vyshinskaya, S. L. Gutorov, I. V. Sagaydak, A. N. Polyakov, Yа. V. Vishnevskaya, Yu. I. Patyutko, M. R. Lichinitser

“…Background. At present liver resection combined with chemotherapy is the only treatment for isolated resectable colorectal cancer liver metastases that…”
Get full text

Bondronat v forme dlya priema vnutr' effektiven u bol'nykh s kostnymi metastazami raka molochnoy zhelezy. Opyt odnogo tsentra by N N Semenov, M R Lichinitser, G V Vyshinskaya, A A Meshcheryakov, V V Novikov, S L Gutorov, E I Borisova, T A Nakhalova, Z P Mikhina, N V Lyubimova, E A Chaklina, N N Aplevich

“…Бисфосфонаты в онкологии сегодня эффективно применяются у больных с метастазами в кости различных злокачественных опухолей.На сегодняшний день изучены и…”
Get full text

Opyt primeneniya abitaksela™ v lechenii solidnykh opukholey by A G Blyumenberg, S L Gutorov, S V Topchieva, V A Gorbunova, M R Lichinitser

“…Паклитаксел - противоопухолевый препарат, широко применяемый в первой и второй лини и химиотерапии рака яичников , молочной железы , немелкоклеточного рака…”
Get full text

Perifericheskaya neyrotoksichnost' taksotera by I N Shakirova, L I Lebedeva, T A Borisova, A A Meshcheryakov, R A Setdikov, S L Gutorov

“…В работе отражены результаты изучения периферической нейротоксичности таксотера в рамках клинических исследований новых противоопухолевых цитостатиков,…”
Get full text

Capillarization of the myocardium of the yak by Belkin, V S, Astakhov, O B, Gutorov, S L

“…Organometric and histometric characteristics of various parts of the heart have been performed in the yak, a permanent inhabitant at altitudes of 3,000-5,000 m…”
Get more information

The use of cyclosporin A in treating partial red-cell aplasia of the bone marrow and aplastic anemia by Pivnik, A V, Idel'son, L I, Kravchenko, S K, Gutorov, S L, Rasstrigin, N A, Pustovoĭt, L A, Kremenetskaia, A M

Get more information